Welcome to UE Central Library

Keep Smiling

Molecules and medicine / (Record no. 116)

MARC details
000 -LEADER
fixed length control field 05763cam a22002894a 4500
001 - CONTROL NUMBER
control field 964
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20200611124316.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 070716s2007 njua b 001 0 eng
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780470227497 (pbk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0470227494 (pbk.)
040 ## - CATALOGING SOURCE
Transcribing agency DLC
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1
Edition number 22
Item number C7975
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Corey, E. J.
245 10 - TITLE STATEMENT
Title Molecules and medicine /
Statement of responsibility, etc E.J. Corey, B. Czakó and L. Kürti.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Hoboken, N.J. :
Name of publisher, distributor, etc John Wiley & Sons,
Date of publication, distribution, etc 2007
300 ## - PHYSICAL DESCRIPTION
Extent xii, 254 p.
Other physical details ill. (some col.) ;
Dimensions 26 cm.
500 ## - GENERAL NOTE
General note Includes bibliographical references and index.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Molecules.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Molecular biology.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical Preparations.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Molecular Biology
General subdivision methods.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Czakó, Barbara.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kürti, László,
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Books
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note 1. Part i. Introduction. <br/>2. Understanding structural diagrams of organic molecules. <br/>3. Some common molecules. <br/>4. Proteins and three-dimensional protein structure. <br/>5. Some of the protein structures that appear in this book. <br/>6. Part ii. Inflammatory, cardiovascular and metabolic diseases. <br/>7. Anti-inflammatory agents. <br/>8. Acetylsalicylic acid aspirin™). <br/>9. Naproxen (aleve™). <br/>10. How do anti-inflammatory drugs work? <br/>11. Other eicosanoids in inflammation. <br/>12. An overview of inflammation. <br/>13. Celecoxib (celebrex™). <br/>14. Prednisone (deltasone™). <br/>15. Methotrexate (trexall™). <br/>16. Allopurinol (zyloprim™). <br/>17. Antiasthmatic and antiallergic agents. <br/>18. Salmeterol (serevent™). <br/>19. Fluticasone propionate (flovent™). <br/>20. Montelukast sodium (singulair™). <br/>21. Tiotropium bromide (spiriva™). <br/>22. Loratadine (claritin™). <br/>23. Type 2 diabetes. <br/>24. An overview of metabolic syndrome. <br/>25. Antidiabetic and cholesterol-lowering agents. <br/>26. Metformin (glucophage™). <br/>27. Glipizide (glucotrol™). <br/>28. Pioglitazone (actos™. <br/>29. Sitagliptin (januvia™. <br/>30. Atorvastatin (lipitor™. <br/>31. Ezetimibe (zetia™. <br/>32. Cardiovascular agents. <br/>33. Atenolol (tenormin™. <br/>34. Enalapril (vasotec™. <br/>35. Candesartan cilexetil (atacand™. <br/>36. Aliskiren (tekturna™. <br/>37. Amlodipine (norvasc™. <br/>38. Nitroglycerin. <br/>39. Clopidogrel bisulfate (plavix™. <br/>40. Digoxin (lanoxin™. <br/>41. Receptors and signaling. <br/>42. Information flow into the cell by chemical signaling. <br/>43. References for part ii. <br/>44. Part iii. Reproductive medicine. <br/>45. Oral contraceptives. <br/>46. Testosterone. <br/>47. Mifepristone (mifeprex™. <br/>48. Oxytocin (oxytocin™. <br/>49. Sildenafil (viagra™. <br/>50. Osteoporosis. <br/>51. Some aspects of osteoporosis. <br/>52. Alendronate (fosamax™. <br/>53. Calcitriol (rocaltrol™. <br/>54. Raloxifene (evista™. <br/>55. Teriparatide (forteo™. <br/>56. Glaucoma and antiulcer agents. <br/>57. Latanoprost (xalatan™. <br/>58. Ranitidine (zantac™. <br/>59. Omeprazole (prilosec™. <br/>60. References for part iii. <br/>61. Part iv. Autoimmune disease and organ transplant. <br/>62. A brief survey of the immune system. <br/>63. Immunosuppressive agents. <br/>64. Azathioprine (imuran™. <br/>65. Mycophenolate mofetil (cellcept™. <br/>66. Cyclosporin (neoral™. <br/>67. Tacrolimus (prograf™. <br/>68. Fty720 (fingolimod). <br/>69. Infectious diseases. <br/>70. Antibiotics. <br/>71. Amoxicillin (amoxil™. <br/>72. Cefaclor (ceclor™. <br/>73. Doxycycline (vibramycin™. <br/>74. Azithromycin (zithromax™. <br/>75. Ciprofloxacin (cipro™. <br/>76. Trimethoprim (triprim™. <br/>77. Amikacin (amikin™. <br/>78. Vancomycin (vancocin™. <br/>79. Linezolid (zyvox™. <br/>80. Isoniazid (laniazid™. <br/>81. Ancillary antibiotics. <br/>82. Drug resistance. <br/>83. Antiviral agents. <br/>84. On viruses and viral diseases. <br/>85. Acyclovir (zovirax™. <br/>86. Ribavirin (virazole™. <br/>87. Oseltamivir (tamiflu™. <br/>88. Zidovudine (retrovir, azt™. <br/>89. Zalcitabine (hivid™. <br/>90. Nevirapine (viramune™. <br/>91. Efavirenz (sustiva™. <br/>92. Lopinavir + ritonavir (kaletra™. <br/>93. Uk427857 (maraviroc). <br/>94. Antifungal agents. <br/>95. Amphotericin (fungizone™. <br/>96. Fluconazole (diflucan™. <br/>97. Caspofungin (cancidas™. <br/>98. Terbinafine (lamisil™. <br/>99. Antimalarial and antiparasitic agents. <br/>100. Parasitic diseases: a focus on malaria. <br/>101. Chloroquine (aralen™. <br/>102. Artemether + lumefantrine (coartem™. <br/>103. Atovaquone + proguanil (malarone™. <br/>104. Miltefosine (impavido™. <br/>105. Nitazoxanide (alinia™. <br/>106. Ivermectin (stromectol™. <br/>107. References for part iv. <br/>108. Part v. Malignant disease. <br/>109. An overview of cancer. <br/>110. Capecitabine (xeloda™. <br/>111. Carboplatin (paraplatin™. <br/>112. Vinblastine (velban™. <br/>113. Paclitaxel (taxol™. <br/>114. Cyclophosphamide (cytoxan™. <br/>115. Tamoxifen (nolvadex™. <br/>116. Irinotecan (camptosar™. <br/>117. Bleomycin (blenoxane™. <br/>118. Imatinib (gleevec™. <br/>119. Sunitinib (sutent™. <br/>120. Bortezomib (velcade™. <br/>121. Ancillary anticancer agents. <br/>122. References for part v. <br/>123. Part vi. Drugs acting on the nervous system. <br/>124. Pain and analgesia. <br/>125. Lidocaine (xylocaine™. <br/>126. Morphine (avinza™. <br/>127. Acetaminophen (tylenol™. <br/>128. Fentanyl (duragesic™. <br/>129. Sodium thiopental (sodium pentothal™. <br/>130. Gabapentin (neurontin™. <br/>131. Diazepam (valium™. <br/>132. Sumatriptan (imitrex™. <br/>133. Hypnotics (insomnia) and antismoking. <br/>134. Zolpidem (ambien™. <br/>135. Ramelteon (rozerem™. <br/>136. Varenicline (chantix™. <br/>137. The brain, neurotransmission and molecular neurotransmitters. <br/>138. Neurodegenerative and psychiatric diseases. <br/>139. Levodopa (larodopa™. <br/>140. Donepezil (aricept™. <br/>141. Antiepileptic agents. <br/>142. Antianxiety agents. <br/>143. Antidepressants. <br/>144. Antipsychotics. <br/>145. References for part vi. <br/>146. Glossary. <br/>147. Index.<br/>
Holdings
Withdrawn status Damaged status Not for loan Home library Current library Date acquired Source of acquisition Full call number Barcode Date last seen Price effective from Koha item type
      UE-Central Library UE-Central Library 21.05.2018 U.E.15199 615.1 C7975 T964 21.05.2018 21.05.2018 Books
Copyright © 2023, University of Education, Lahore. All Rights Reserved.
Email:centrallibrary@ue.edu.pk